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ABSTRACT
Objective: The primary objective of the study was to assess the awareness, knowledge, and practice of pharmacovigilance (PV) among the practicing 
doctors. The secondary objective was to ascertain the reason for underreporting of adverse drug reactions (ADRs) in India.
Methods: A cross-sectional study was conducted using a pretested and validated questionnaire. The questionnaire was designed to assess these 
parameters of PV. These questionnaires were distributed among 90 doctors to ascertain the answers. In addition, the same parameters were 
reassessed (post-questionnaires) after sensitizing the doctors about PV.
Results: Only 52 doctors took the posttest, a response rate of 57%. The mean awareness, knowledge, and practice of PV among doctors were 4.70, 
3.60, and 2.90, respectively, which significantly increased in post-test questionnaire (p<0.05). The Pearson correlations revealed that the level of 
awareness among the respondents was significantly related to the knowledge and the practice of PV, linearly, and positively. In other words, higher the 
awareness more was the knowledge and better was the methods of application. The most common factor discouraging doctors from reporting ADRs 
was they found it difficult to decide whether ADR has occurred or not (32.69%).
Conclusion: There was a significant positive correlation between awareness, knowledge, and practice of PV. In spite of these findings, the ADR 
reporting rate is negligible in India. To bring about a strong culture of reporting among doctors, it is mandatory to continuously expose doctors to the 
concepts of PV by continuous medical education, workshops, seminars and to make reporting mandatory in India.
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INTRODUCTION
Adverse drug reactions (ADRs) are an important cause of morbidity 
and mortality worldwide. According to the World Health Organization 
(WHO) definition, an ADR is any noxious, unintended, and undesired 
effect of a drug, which occurs at the doses which are used in humans for 
prophylaxis, diagnosis, or therapy [1]. Overall, the cost of drug-related 
morbidity and mortality exceeded $177.4 billion in 2000, hospital 
admission accounted for nearly 70%. This pandemic is ascribed 
to unnecessary prescribing, imprecise diagnosis, the outstanding 
development of new drugs, and unjustified promotion [2]. It has been 
estimated that ADR’s account for approximately 5% of all hospital 
admissions, 10-20% occur during hospitalization and are responsible 
for 7-9% of hospitalization days [3]. Even these startling figures do 
not represent the whole picture as these studies generally excluded 
ADRs caused by overdose, drug abuse, or therapeutic failures. The cost 
to most countries for managing ADRs is considerable and constitutes 
a significant economic burden on the patient and society at large. 
Merely, the history of years of use of a drug in millions of patients with 
an established drug also is not a guarantee of its safety. The recent 
literature of risk associated with the use of rosiglitazone (myocardial 
infarction) and rimonabant (psychiatric side effects) highlights the 
tightrope walk for physicians, who balance risk and benefits in an 
individual patient [4,5].
Pharmacovigilance (PV) is, “The science and the activities which relate 
to the detection, assessment, understanding, and the prevention of 
adverse effects or any other drug-related problems” [6]. Even with 
all animal studies, clinical data, we do not know if a compound is safe 
for humans. At best it is “not unsafe.” Thus, the physician has the most 
important role to play in PV, not merely because he is the first person 
to whom the patient will come with symptoms but also he is in a better 
position to suspect an ADR. The cost of a PV system, compared with 
the cost of ADRs to a nation and to the total national expenditure 
on medicines, is small. In the last decade, there has been a growing 
awareness that the scope of PV should be extended beyond the strict 
confines of detecting new signals of safety concerns. In recent past 
reporting of ADRs are the main cause of withdrawal of many drugs, 
viz., rofecoxib, cisapride, and terfenadine [7,8]. In a meta-analysis of 39 
prospective studies from hospitals in the United States, it was shown 
that ADRs ranked fourth to sixth leading cause of death [9].
In a country like India, with a large population and vast diversity, it 
is absolutely necessary to have a standard PV program. India ranks 
below 1% in terms of ADR reporting against the world rate of 5% [10]. 
Underreporting of ADRs is very common. It has been estimated 
that only 6–10% of all the ADRs are reported [11]. This high rate of 
underreporting is a matter of great concern which delays detection 
of serious ADRs, and consequently, has major negative impact on the 
public health. To overcome this problem, the Ministry of Health and 
Family Welfare, Government of India, has initiated the National PV 
Programme [12].
The present low level of ADR reporting is mostly due to a lack of 
awareness, training, and time constraints to the busy doctors. The 
crucial endurance is to create a culture of reporting among the health 
care professionals, especially among the treating physicians, as they 
are more closely associated with patient care. The previous reported 
published studies have found that underreporting of ADR is related 
with shortcomings in the knowledge, attitude, and perception among 
healthcare professionals.
Most of the similar published studies from India have not included 
doctors from the public health centers (PHC). These PHC doctors treat 
the maximum number of patients usually from a rural background with 
poor literacy rate; still, they are the least informed about PV. Hence, 
we have made a sincere attempt to include such doctors in the study. 
In addition, all previous studies are just passive questionnaire-based 
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studies, we have gone a step ahead and sensitized the doctors with 
90 minutes presentation on various aspects of PV and again captured 
the data post-sensitizing.
METHODS
This was a cross-sectional questionnaire-based study conducted at a 
tertiary care teaching hospital. The approval for conducting this study 
was obtained from the Institutional Ethics Committee of the College. 
This was an interventional study which was done among medical 
officers who gave their informed consent working in government 
PHC and doctors of various preclinical and clinical departments and 
postgraduates students from tertiary care teaching hospital. Those 
participants who did not return the questionnaires both pre- and 
postquestionnaire included in the stipulated time were excluded from 
the study. The study instrument was a pre-designed questionnaire 
which was structured to obtain information on the knowledge of the 
ADRs reporting, the attitudes toward the reporting, and the factors 
that in practice could hinder the reporting among the doctors. The 
questionnaires were set-based on similar published studies and 
validated. The questionnaire was designed in such a way that each 
question had only one correct answer. The questionnaires were 
administered to 90 doctors.
The questionnaire comprised 20 questions (awareness - 6, 
knowledge, – 5 and practice - 9). The participants were briefed 
about the questionnaire. They were given 20 minutes to answer the 
questionnaire. They could maintain anonymity with regard to their 
names but had to write their medical registration numbers. Once the 
participant doctors completed and returned the pre-questionnaire, 
they were sensitized to various aspects of PV in two power point 
presentation of 45 minutes each. Postpresentations again all doctor 
were given the same pre-questionnaire to evaluate their sense of 
understanding. The questionnaires were, then, analyzed by grading the 
respondents into three categories: Poor, unsatisfactory, and satisfactory 
as shown in Table 1.
Statistical analysis
Spearman’s correlation was used to determine the relationship 
between awareness, knowledge, and practice of PV among the doctors. 
The mean and standard deviation of descriptive values was calculated, 
paired students t-test was used to find the statistical difference of mean. 
A p<0.05 was considered as significant. SPSS version 16 was used for 
analysis.
RESULTS
Out of 90 doctors, only 52 doctors took the post-test, a response rate 
of 57%. The mean awareness, knowledge, and practice of doctors 
were 4.70, 3.60, and 2.90, respectively, in pretest questionnaire which 
significantly increases in post-test questionnaire, p<0.05, as given in 
Table 2.
The relationship between the awareness, knowledge, and practice of 
PV among the doctors was investigated using Pearson’s correlation 
coefficient. Preliminary analyses were performed to ensure that there 
was no violation of the assumption of the normality and linearity. 
It revealed that the level of awareness among the respondents was 
significantly related to the knowledge and the practice of PV, linearly, 
and positively with correlation coefficients of 0.414 and 0.325, with 
significance levels of 0.002 and 0.01, respectively. In other words, higher 
the awareness more was the knowledge and better was the methods of 
application. Likewise, the knowledge and practice were significantly 
and positively related to a correlation coefficient of 0.457, a significance 
level of 0.001 as shown in Table 3.
Data were also analyzed and presented as a percent (%) of the 
respondents as below.
Knowledge
Although 98% of the doctors were aware of the term PV, only 40% of 
doctors knew the meaning of PV. 76.92% of doctors knew the aim of 
PV but 33% of doctors do not think reporting of ADRs is a professional 
obligation to them. The majority of doctors (88.46%) knew that 
health-care professionals such as doctors, pharmacist, and nurse are 
responsible for reporting ADR in hospital. 92.3% of doctors think that 
PV should be taught in detail to all healthcare professionals.
Attitude
Only 75 % of doctors could define PV correctly, but the majority of 
them (88.46%) knew the central drugs standard control organization 
(CDSCO) are the regulatory body responsible for monitoring ADRs. 
Around 45% of doctors did not know rare ADRs are detected in 
phase IV of clinical trials and the WHO’s online database for reporting 
ADRs are vigiBase. Almost 80% of the doctors knew PV includes drug-
related problem, blood transfusion,  herbal products, medical devices, 
and vaccines.
Practice
Among the participants, 73% have experienced ADRs in patients, 
57.69% have seen the ADR reporting form but only 44.29% have 
reported an ADR to PV center. Although 84.61% of doctors knew 
what constitutes serious ADR such as life-threatening event, 
disability, birth defects, hospitalization, and death, merely 30.76% 
knew that death should be reported within one day. Fortunately, the 
majority of doctors (88.46%) knew ADRs are done for new drugs, 
major, and unexpected reactions of old drugs and any reaction 
or even minor reactions of new drug. Coming to the causality and 
severity of ADRs, only 55.76% of doctors knew it is done by Naranjo 
algorithm, and merely 32.69% knew severity is assessed by Modified 
Hartwig scale. A sincere attempt was made to find out the factors 
discouraging doctors from not reporting ADRs. The various reasons 
were no remuneration for reporting, lack of time to report ADRs 
due to their busy schedule, feeling a single unreported case may not 
affect ADR database or is not going to make a big difference. The most 
interesting fact was the majority of doctors, 32.69% found it was 
difficult to decide whether ADR has occurred or not.
Table 1: Grading of respondents (score range)
Level Poor Unsatisfactory Satisfactory Max possible 
score
Awareness 1-2 3-4 5-6 6
Knowledge 1-2 3 4-5 5
Practice of PV 1-2 3 4-5 5
PV: Pharmacovigilance
Table 2: Descriptive statistics of awareness, knowledge, and practice of PV among doctors
Components Pre test Post test Paired t‑test
Mean Standard deviation Mean Standard deviation t value p value
Awareness 4.70 1.02 5.13 0.95 −3.976 p<0.000
Knowledge 3.60 1.40 4.34 1.12 −3.825 p<0.000
Practice 2.90 0.91 3.69 1.04 −4.361 p<0.000
All values are expressed as mean±SD of 52 doctors for awareness, knowledge, and practice of PV, means of pre-test and post-test differ significantly (p<0.05). 
PV: Pharmacovigilance, SD: Standard deviation
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DISCUSSION
Adverse reaction monitoring and reporting are very important in 
identifying the adverse reaction trends and to minimize or prevent 
harm to patients arising from their drugs [13]. In a country like 
India with multiethnic groups and a high rate of use of herbal and 
alternative medicine with allopathic medicines, physicians can play a 
major role in detecting and reporting ADRs. Various factors based on 
knowledge, attitude, and perception of the health professionals have 
been attributed for underreporting of ADRs. Inman has described them 
as “seven deadly sins,” these includes lack of incentives, litigation, and 
complacency, belief that the ADR has to be reported only if it is related 
to the drug, indifference that this single report is not going to make a 
big difference, ignorance that only serious and or unexpected ADRs 
are necessary to be reported, and lethargy to report stating no time to 
report, or no forms or other excuses [14].
In the current study, only 40% knew the correct meaning of PV, 33% of 
the doctors do not think reporting of ADRs are a professional obligation 
to them, and 45% of doctors did not know rare ADRs are detected 
in Phase IV of clinical trials. Similar results were seen in a study by 
Hardeep and Rakesh among health-care professionals in teaching 
hospital in northern India [15].
Among the doctors, 73% have seen ADRs in patients, 57.69% have 
seen the ADR reporting form but only 44.29% have reported an ADR 
to PV center. In a similar study done by Gupta et al. found 64.4% 
have experienced ADRs among patients and 58.4% have seen an 
ADR reporting form, but only 22.8% have ever reported ADR to PV 
center [16].
The factors discouraging participants from reporting ADRs were no 
remuneration (5.76%), lack of time to report ADR (50.52%), belief 
that a single unreported case may not affect ADR database (11.15 %), 
and difficulty to decide whether ADR has occurred or not (32.69%). In 
a similar study by Gupta et al. found these rates to be 31.7%, 23.8%, 
21.8%, and 22.8%, respectively [16]. Although this study sited lack of 
remuneration as the major cause of under-reporting of ADRs, our study 
sited difficulty to decide whether ADR has occurred or not. Whereas 
a study by Hardeep and Rakesh found the most common practical 
difficulty which was faced by the doctors in the reporting of ADRs were 
that a majority of them (60.6%) did not know how and where the ADRs 
had to be reported.
This study revealed that the level of awareness among the responders 
was significantly related to knowledge and practice of PV, positively 
and linearly. In a similar study by Hema et al. revealed that the level 
of awareness among the respondents was significantly related to the 
knowledge and the methods of application of PV, linearly and positively 
with correlation coefficients of 0.346 and 0.444, with significance levels 
of 0.001 and 0.001, respectively. The knowledge and the methods were 
significantly and positively related with a correlation coefficient of 
0.485, p<0.001 [12].
The effectiveness and success of any PV system depend highly on the 
knowledge, attitude, and perception of the practicing physician. To 
improve the reporting rate, it is vital to address the above issues in the 
health-care professionals with regards to the ADR reporting. There is 
also a requirement for constant training and enactment of regulations 
for ADR reporting among health-care professionals. Despite recent 
implementation of well-structured PV program of India in accordance 
with the objectives and recommendations of the WHO by CDSCO, 
desired success is still a distant dream [17]. With a strong knowledge of 
PV and using this knowledge in daily practice will enhance the number 
of ADRs reported. Hence, the safety data of products prescribed will 
increase and lead to better understanding of drugs and rational drug 
prescription.
CONCLUSION
This study clearly identifies gaps in awareness, knowledge, and practice 
of PV among doctors. There was a significant positive correlation 
between awareness, knowledge, and practice of PV. In spite of these 
findings, the ADR reporting rate is negligible in India. The major 
limitation of the study was the small sample size. In addition, some 
other factors that are associated with self-reporting studies such as 
accuracy of recall, personal bias could have also affected the results of 
this study. To bring about a strong culture of PV and reporting among 
doctors it is mandatory to continuously expose doctors to the concepts 
of PV by bringing about curriculum change in undergraduate teaching 
and have a regular continuous medical education, workshops, and 
seminars in PV or to make reporting mandatory in India.
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